Angela Barbera, MD
Retina Specialist · Wyomissing, PANPI 1356577340
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 25.3% of the total.
Across 132 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$789
- Genentech USA, Inc.$535
- Regeneron Healthcare Solutions, Inc.$433
- Tarsus Pharmaceuticals, Inc.$204
- Eyepoint US, Inc.$167
- Alcon$155
- plus $831 from 14 others
What the payments were for
- Food & beverage$3,115100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $789 |
| Genentech USA, Inc. | 17 | $535 |
| Regeneron Healthcare Solutions, Inc. | 19 | $433 |
| Tarsus Pharmaceuticals, Inc. | 3 | $204 |
| Eyepoint US, Inc. | 3 | $167 |
| Alcon | 6 | $155 |
| Alimera Sciences, Inc. | 8 | $155 |
| Astellas Pharma Global Development | 1 | $150 |
| Astellas Pharma US Inc | 7 | $134 |
| Glaukos Corporation | 1 | $82 |
| Apellis Pharmaceuticals, Inc. | 4 | $79 |
| Novartis | 4 | $77 |
| Merz Pharmaceuticals, LLC | 1 | $31 |
| Coherus Oncology, Inc. | 1 | $24 |
| Genentech, Inc. | 1 | $22 |
| Rayner Intraocular Lenses Limited | 1 | $19 |
| Thea Pharma Inc. | 1 | $18 |
| Spark Therapeutics, Inc. | 1 | $15 |
| Bausch & Lomb Americas Inc. | 1 | $13 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,115 in reported general payments places this provider in the 60th percentile of 43 retina specialist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Difluprednate | 65 | $7,737 |
| RocklatanNetarsudil Mesylat/Latanoprost | 12 | $4,067 |
| Prednisolone Acetate | 104 | $3,443 |
| Brimonidine Tartrate | 22 | $1,420 |
| Latanoprost | 47 | $600 |
| ErythromycinErythromycin Base | 59 | $526 |
| Ofloxacin | 46 | $395 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 36 | $367 |
| Ketorolac Tromethamine | 34 | $363 |
| Timolol Maleate | 21 | $91 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Wyomissing
- Moiz CarimWyomissing$6K
- Anastasia TrabandWyomissing$4K
- Tapan PatelWyomissing$3K
- Barry MalloyWyomissing$2K
- Joshua GreenePhiladelphia$394K
- Jay ChhablaniPittsburgh$70K
- Sachin PatelPottsville$17K
- Brian VanderbeekPhiladelphia$14K
- Thucanh MultererFogelsville$9K
- Christopher BairHermitage$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.